This study investigates concanavalin A (ConA) as a novel factor that may enhance osteogenesis of mesenchymal stem cells (MSCs) in vitro. Various factors, such as cytokine bone morphogenetic protein-2 (BMP-2), have been studied for their possible promotion of MSC osteogenesis in vivo and in vitro. However, the factor that might be safer, more effective, and less expensive than these has not been determined. We therefore cultured human MSCs in osteogenic medium in the presence or absence of ConA, and used calcium assays to compare the effects of ConA and BMP-2 on MSC calcification. We also used enzyme-linked immunosorbent assay (ELISA) and quantitative polymerase chain reaction (PCR) to evaluate the expression levels of bone-specific markers. ConA and BMP-2 enhanced calcification with comparable effectiveness. The combination of ConA and BMP-2 further enhanced calcification slightly but significantly. ConA also increased osteocalcin and BMP-2 protein levels in MSC culture medium. Furthermore, ConA increased osteocalcin, RUNX2, BMP-2, BMP-4, and BMP-6 mRNA expression levels. However, the gene expression pattern of ConA-stimulated MSCs was different from that of MSCs stimulated by BMP-2. Together, these results suggest that ConA and BMP-2 enhance MSC osteogenesis via different pathways. ConA-induced bone formation in MSC cultures may be useful in regenerative medicine or tissue engineering in clinical studies, as well as in basic research on bone formation. (Int J Artif Organs 2008; 31: 708-15) 
INTRODUCTION
Mesenchymal stem cells (MSCs) have multilineage developmental potential and can differentiate into osteoblasts, chondrocytes, or adipocytes (1) . They can be easily obtained by bone marrow aspiration. Furthermore, they can be expanded on a large scale in vitro (2) . The use of MSCs in tissue engineering techniques can also promote the regeneration of various tissues such as bone and cartilage (3) (4) (5) (6) .
After transplantation, MSCs that have differentiated into osteoblastic cells in vitro promote bone regeneration more prominently than do undifferentiated MSCs (7, 8) . Until now, many cytokines, such as bone morphogenetic protein-2 (BMP-2), transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF-I) (9) (10) (11) , along with prostaglandin E (PGE) (12) and statin (13) , have been studied as promoting factors of MSC osteogenesis in vivo and in vitro. However, it is unknown whether other factors might be safer, more effective, and less expensive than these. In this study, we investigated concanavalin A (ConA) as a novel factor that may enhance MSC osteogenesis in vitro. This protein with sugar-binding properties activates lymphocytes (mitogen activity), aggregates erythrocytes (14) (15) (16) , and is useful in distinguishing cancer cells from normal cells (17) . ConA also strengthens cell adhesion to various scaffolds (18) . It may therefore have various applications in regenerative medicine. It promotes the formation of bone-and cartilage-like tissues at the periosteum in vivo (19, 20) and in chondrocytes in vivo (20, 21) . However, ConA's effects on MSC osteogenesis are not fully understood. In this study, we examined the efficacy of ConA for inducing osteogenesis in vitro.
MATERIALS AND METHODS

Materials
ConA (Sigma, St. Louis, MO, USA) was adjusted with phosphate-buffered saline (PBS) to 1 mg/mL quantified by the Lowry protein assay. BMP-2 was obtained from Yamanouchi Pharmaceutical (Tokyo, Japan). BMP-2 was adjusted to 300 µg/mL with LE6 buffer (pH 4.5, 5 mM Lglutamine, 5 mM NaCl, 2.5% glycine, 0.5% sucrose, and 0.01% Tween 80, all of which were obtained from Sigma). BMP-2 was further diluted with PBS and added to the culture medium.
Cell cultures
Human MSCs were purchased from Cambrex Bio-Science (Walkersville, MD, USA). These cells were identified as CD105-, CD166-, CD29-, and CD44-positive and CD14-, CD34-, and CD45-negative by flow cytometric analysis. The multipotency of the cells was confirmed by the company. MSCs were maintained with Dulbecco's modified Eagle's medium (DMEM; Sigma) supplemented with 10% fetal bovine serum (FBS; Gibco BRL, Gaithersburg, MD, USA) and antibiotic-antimycotic (100 U/mL penicillin G, 100 µg/mL streptomycin, and 0.25 mg/mL amphotericin B; Gibco BRL) (Medium A) at 37°C in 5% CO 2 /95% air. MSCs obtained from the cultures at passages 3-5 were used for the experiments. MSCs were seeded at 5x10 3 cells/cm 2 in Medium A for each experiment. After the MSCs reached confluence, the medium was changed to osteogenic medium (Minimum Essential Alpha Medium [Gibco BRL] containing the antibiotic-antimycotic mentioned above, 10 -8 M dexamethasone [Dex; Sigma], 10 mM β-glycerophosphate [Sigma], and 50 mg/mL ascorbic acid 2-phosphate [Sigma]) The effects of ConA or BMP-2 on MSC osteogenesis were then analyzed as follows.
Alizarin red staining
MSCs were cultured on 48-well tissue culture plates (5-mm diameter) (BD Biosciences, Franklin Lakes, NJ, USA). After the MSCs reached confluence, the medium was changed to osteogenic medium with or without ConA. After 14 days, the culture medium was aspirated, and the cell layer was washed twice with 10 mM Tris buffer containing 0.9% NaCl (pH 7.6). The cell layers were fixed for 1 hour with 200 µL 95% ethanol. The fixed cell layers were stained with 200 µL 1% alizarin red S solution (Chroma-Gesellschaft Schmid, Köngen, Germany) for 5 minutes under shading at room temperature. After the cell layers were washed twice with water, a photographic image was obtained.
Calcium content
MSCs were cultured in 48-well tissue culture plates. After they reached confluence, the medium was changed to osteogenic medium with ConA (8 µg/mL) or with a combination of ConA and BMP-2. After 14 days, the medium was aspirated, the cell layers were washed twice with 200 µL PBS, and 200 µL 10% trichloroacetic acid solution was then added to the cultures. The cells and extracellular matrix were homogenized for 10 seconds using Vibracell (Sonics & Materials, Newtown, CT, USA), and 11 µL 10 N NaOH was added for neutralization. The extracts were used for calcium quantification using a Ca C-test Wako kit (Wako Pure Chemical Industries, Osaka, Japan) and a Multiwell spectrophotometer (Immuno Mini NJ-2300; Nalge Nunc International, Rochester, NY, USA). The calcium ion concentration was determined at a wavelength of 570 nm.
Enzyme-linked immunosorbent assay
MSCs were cultured in 175-cm 2 flasks. After they reached confluence, the medium was changed to osteogenic medium with or without ConA (8 µg/mL). Twenty-four hours before the end of the culture, the medium was changed to phenol red-free DMEM supplemented with 1% antibiotic-antimycotic alone. After culturing, the medium was collected and ultrafiltrated by Amicon Ultra-4 10,000 NMWL (Millipore, Billerica, MA, USA). The concentrated fraction was then used for total protein quantification using the Protein Quantification Kit-Rapid (Dojindo Laboratories, Kumamoto, Japan) and for quantification of the osteocalcin, BMP-2, and BMP-4 proteins using the Gla-type Osteocalcin EIA kit (TaKaRa Bio, Shiga, Japan), the Quantikine Human BMP-2 Immunoassay, and the Quantikine Human BMP-4 Immunoassay (R&D Systems, Minneapolis, MN, USA), respectively.
Real-time polymerase chain reaction
MSCs were cultured on 90-mm diameter tissue culture plates (BD Biosciences). After they reached confluence, the medium was changed to osteogenic medium with or without ConA (8 µg/mL) or BMP-2 (50 ng/mL) separately. After 3-21 days of culture, the cell layers were washed twice with PBS. Total RNA was extracted using TRI Reagent (Sigma) and the RNeasy Mini Kit (Qiagen, Hilden, Germany). DNA was then degraded by DNAse I (Invitrogen, Carlsbad, CA, USA). Total RNA concentrations were measured by an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA), and the total RNA content was then calculated. Total RNA was reverse-transcribed with the Omniscript RT kit (Qiagen) and Oligo-dT Primer (Promega, Madison, WI, USA) according to the manufacturers' protocols. Gene expression was analyzed with a TaqMan probe (Sigma), Absolute QPCR ROX Mix (AB Gene, Epsom, UK), and the 7900HT Fast Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). The following forward (F), reverse (R), and probe (P) pairs were employed: alkaline phosphatase (ALP) F: The results were analyzed by a relative quantitative analysis method after correction with 18s ribosome RNA (TaqMan Gene Expression Assays; Applied Biosystems) as an internal control.
Statistical analysis
Data are presented as the means of 3 independent experiments ± SD. Unless otherwise specified, paired ttests were used when we compared test values with the control value. For comparisons among groups, 1-way ANOVA with the Tukey post hoc test was used.
RESULTS
Calcification
Cell layers in MSC cultures maintained in osteogenic medium were stained with alizarin red to evaluate the degree of calcification. ConA enhanced calcification by day 14 (Fig. 1A) . The calcium contents of the cell layers were determined in order to compare the effects of ConA and BMP-2 on MSC calcification. ConA increased calcium levels dose-dependently, and the effect peaked at 8 µg/mL. The maximum effect of ConA was similar to that of BMP-2 at >50 ng/mL ( Fig. 1B, C) . The effect of these factors combined was determined in another independent culture. In the simultaneous presence of ConA, BMP-2 slightly but significantly increased calcium levels (Fig. 2 ).
Osteocalcin
Levels of osteocalcin, a bone-specific matrix protein, were quantified by enzyme-linked immunosorbent assay (ELISA). ConA reduced the osteocalcin level in MSC culture on day 3; however, it was not significant. The levels did not increase until day 14 regardless of the presence or absence of ConA. On day 21, ConA significantly increased the osteocalcin level in MSC culture medium compared with the day 21 of control cultures without ConA (Fig. 3) .
Expression of bone-related genes
The mRNA level of each of several bone-related genes (BMP-2, BMP-4, BMP-6, BMP-7, BMP-9, alkaline phosphatase [ALP], osteocalcin, and RUNX2) in the presence of 8 µg/mL ConA or 50 ng/mL BMP-2 was determined using real-time polymerase chain reaction (PCR) analysis. BMP-2 increased the ALP mRNA expression level, whereas no appreciable ALP up-regulation was observed with ConA ( Fig. 4A ). BMP-2 and ConA each increased osteocalcin ( Fig. 4B ) and RUNX2 (Fig. 4C ) mRNA levels on day 21. In addition, BMP-2 increased the expression of BMP-2 and BMP-6 but not BMP-4 throughout the whole culture period (Fig. 4D, E, F) . In contrast, ConA increased BMP-2, BMP-4 and BMP-6 expressions on day 14. BMP-7 and BMP-9 could not be detected at any point in the culture period.
Fig. 1 -Effects of concanavalin A (ConA) and bone morphogenetic protein-2 (BMP-2) on mesenchymal stem cell (MSC) calcification: A)
Cell layers were stained with alizarin red on day 14. MSCs were cultured with either nonosteogenic medium (a), osteogenic medium (b), or ConA (8 µg/mL) added to osteogenic medium (c). Calcium content in MSC cultures in the osteogenic medium containing ConA (0 to 10 µg/mL) (B) or BMP (0 to 300 ng/mL) (C) was quantified on day 14. Data are presented as means ± standard deviation for 3 cultures (*p<0.05, **p<0.01). Similar results were obtained in repeated studies.
Fig. 2 -The effects of a combination of ConA and BMP-2: MSCs
were incubated in the osteogenic medium with 8 mg/mL ConA only or ConA with 50, 100, or 300 ng/mL BMP-2 for 14 days. Data are presented as means ± standard deviation for 3 cultures. For comparison among groups, ANOVA with the Tukey post hoc test was performed (***p<0.001, among groups). Similar results were obtained in repeated studies. Fig. 3 -Osteocalcin levels in the medium of MSC cultures in the presence or absence of ConA: MSCs were incubated in the osteogenic medium with 8 µg/mL ConA for 3-21 days. The osteocalcin protein levels in the medium were quantified by ELISA. Data are presented as means ± standard deviation for 3 cultures (***p<0.001). Similar results were obtained in repeated studies.
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ConA increased BMP-2 protein levels in the culture medium on day 14 (Fig. 5) , whereas BMP-4 protein could not be detected at any point in the culture period.
Nodule formation and cell aggregation
ConA and BMP-2 each induced cell aggregates and calcified nodules in MSC cultures. No difference in morphology was observed between MSC cultures exposed to ConA and those exposed to BMP-2 ( Fig. 6 ).
DISCUSSION
In this study, we found that ConA enhanced calcification in MSC cultures in the presence of the osteogenesis induction medium, and its effect was partly similar to that of BMP-2 which induces ectopic bone formation in vivo (22) . BMP-2 has also been shown to induce osteogenesis in MSC cultures in the presence of β-glycerophosphate and ascorbic acid 2-phosphate in vitro (9) . In this study, BMP-2 increased calcium content in MSC cell layers, and
ConA and BMP-2 together enhanced calcification (Fig. 2 ), suggesting that ConA and BMP-2 induce MSC osteogenesis by different mechanisms. BMP-2 activates smad1/5/8 by combining BMP receptors (BMPR-1 or BMPR-2), and the activated smad1/5/8 combines with 
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ConA (8µg/mL) BMP-2 (50ng/mL) smad4 and controls transcription of bone-related genes (23) (24) (25) (26) . On the other hand, ConA binds to various glycoproteins on the plasma membrane and aggregates cells. It has been reported that ConA has a high affinity for osteogenin/BMP-3 (27) . ConA could thus induce the binding of soluble morphogenetic proteins synthesized by MSCs and make them available at high concentrations to ConA-aggregated cells.
To characterize ConA-induced osteogenesis, we determined the protein levels of osteocalcin and BMP, along with mRNA levels of bone-related genes. In MSC cultures, BMP-2 induced the mRNA expression of ALP, RUNX2, and osteocalcin, as described previously (28) . However, ConA elicited different gene expression patterns: it increased RUNX2 and osteocalcin mRNA expression but did not appreciably increase ALP mRNA expression. BMP-2 increased BMP-2 and BMP-6 mRNA expression, whereas ConA increased BMP-2, BMP-4 and BMP-6 mRNA expression. Dex was reported to induce BMP-6 mRNA expression, and this induction was considered essential for MSC osteogenesis (29) . ConA increased BMP-2 protein content in the MSC culture medium ( Fig. 5 ). BMP-4 protein was absent in the supernatant in spite of the expression of BMP-4 mRNA, but this might be due to the binding of ConA to BMP-4 in the cell layer. Thus, ConA-induced osteogenesis may be at least partly explained by autocrine syntheses of BMP-2 and BMP-4.
ConA induces hepatitis in rats and mice (30) . However, it has been reported that the biological properties of plant lectins make them species-dependent and cell-dependent for their surrounding glycoproteins (31) . Furthermore, ConA can be removed from culture cells by incubation with α-D-mannopyranoside as hapten (32) , and ConA bound to bone grafts produced by this method can be removed before transplantation (18) . ConA or related glycoproteins may therefore be useful in producing bone grafts in vitro. For tissue engineering, bone grafts are often formed with MSCs activated by growth factors such as BMP-2. However, recombinant peptides are expensive. In contrast, ConA is inexpensive, with BMP-2 costing approximately a thousand times more than ConA for a medium change.
In conclusion, we have demonstrated that the addition of ConA to osteogenic medium enhances MSC osteogenesis in vitro. ConA-induced bone formation in MSC cultures may be useful in regenerative medicine or tissue engineering in clinical studies, as well as in basic research on bone formation. 
